These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6757951)

  • 1. Extracorporeal modification of plasma and whole blood.
    Saal SD; Gordon BR
    Prog Clin Biol Res; 1982; 106():375-84. PubMed ID: 6757951
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of Protein-A in the treatment of malignancy: rationale and the NCI experience.
    Messerschmidt GL; Bowles C; Parrillo J; Parker M; Shelhammer J; Dowling R; Osborne L; Corbitt R; McCormack K; Longo D; Deisseroth A
    Prog Clin Biol Res; 1982; 106():385-90. PubMed ID: 6757952
    [No Abstract]   [Full Text] [Related]  

  • 3. Perfusion of plasma over Staphylococcus aureus: release of bacterial products is related to regression of tumor.
    Gordon BR; Matus RE; Hurvitz AI; MacEwen EG; Saal SD; Stenzel KH; Rubin AL; Hyden H
    J Biol Response Mod; 1984; 3(3):266-70. PubMed ID: 6379111
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumoricidal responses in spontaneous canine neoplasms after extracorporeal perfusion over immobilized protein A.
    Terman DS
    Fed Proc; 1981 Jan; 40(1):45-9. PubMed ID: 7450063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An extracorporeal chamber for hemoperfusion with selective effect].
    Hydén H
    Lakartidningen; 1978 Jun; 75(24):2377-80. PubMed ID: 353403
    [No Abstract]   [Full Text] [Related]  

  • 6. Adsorption of plasma from tumor-bearing hosts over protein A--containing nonviable Staphylococcus aureus Cowan I: possible mechanism of antitumor reactions.
    Ray PK; McLaughlin D; Allen P; Bandyopadhyay S; Idiculla A; Clarke L; Mark R; Rhoads JE; Bassett JG; Cooper DR
    J Biol Response Mod; 1984; 3(3):293-302. PubMed ID: 6379112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein A-independent tumoricidal responses in dogs after extracorporeal perfusion of plasma over Staphylococcus aureus.
    Gordon BR; Matus RE; Saal SD; MacEwen EG; Hurvitz AI; Stenzel KH; Rubin AL
    J Natl Cancer Inst; 1983 Jun; 70(6):1127-33. PubMed ID: 6343694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein A tangential flow affinity membrane cartridge for extracorporeal immunoadsorption therapy.
    Jia L; Yang L; Zou H; Zhang Y; Zhao J; Fan C; Sha L
    Biomed Chromatogr; 1999 Nov; 13(7):472-7. PubMed ID: 10534759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis-immunoadsorption for treatment of systemic lupus erythematosus in a dog.
    Matus RE; Scott RC; Saal S; Gordon BR; Hurvitz AI
    J Am Vet Med Assoc; 1983 Mar; 182(5):499-502. PubMed ID: 6339455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma perfusion over immobilized protein A from Staphylococcus aureus for treatment of cancer: observations on the evolution of plasma perfusion systems.
    Terman DS
    Int J Artif Organs; 1982 Mar; 5(2):77-80. PubMed ID: 7095882
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of systemic lupus erythematosus by extracorporeal immunoadsorption.
    Palmer A; Gjorstrup P; Severn A; Welsh K; Taube D
    Lancet; 1988 Jul; 2(8605):272. PubMed ID: 2899250
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with Staphylococcus aureus and protein A in the treatment of canine malignancies.
    Bowles CA; Messerschmidt G; Deisseroth AB
    J Biol Response Mod; 1984; 3(3):260-5. PubMed ID: 6379110
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoadsorbent (IM-P) plasma perfusion in patients with rheumatoid arthritis or SLE.
    Yamazaki Z; Iizuka I; Kanai F; Wada T; Fujimori Y; Takahama T; Asano K; Yoshizawa H; Takahashi T; Ogita T
    Life Support Syst; 1983; 1 Suppl 1():98-101. PubMed ID: 6400736
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer treatment with Staphylococcus aureus protein A.
    Solal-Celigny P; Simeon J; Herrera A; Boivin P
    Biomed Pharmacother; 1985; 39(4):177-86. PubMed ID: 3904855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials with Staphylococcus aureus and protein A in the treatment of malignant disease.
    Messerschmidt GL; Bowles CA; Henry DH; Deisseroth AB
    J Biol Response Mod; 1984; 3(3):325-9. PubMed ID: 6379115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of plasma treatment with purified protein A and Staphylococcus aureus Cowan I on spontaneous animal neoplasms.
    Klausner JS; Miller WJ; O'Brien TD; Branda RF
    Cancer Res; 1985 Mar; 45(3):1263-9. PubMed ID: 3971372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of canine mammary carcinoma after immunoadsorption therapy.
    Holohan TV; Phillips TM; Bowles C; Deisseroth A
    Cancer Res; 1982 Sep; 42(9):3663-8. PubMed ID: 7049360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for selective removal of plasma constituents.
    Pineda AA
    Prog Clin Biol Res; 1982; 106():361-73. PubMed ID: 6757950
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of regression of mammary adenocarcinomas in rats following plasma adsorption over protein A-containing Staphylococcus aureus.
    Ray PK; Raychaudhuri S; Allen P
    Cancer Res; 1982 Dec; 42(12):4970-4. PubMed ID: 7139601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcal protein A in neoplastic disease.
    Terman DS
    J Biol Response Mod; 1984; 3(3):316-24. PubMed ID: 6379114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.